These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 32692871)
1. Increased nuclear factor I/B expression in prostate cancer correlates with AR expression. Nanda JS; Awadallah WN; Kohrt SE; Popovics P; Cates JMM; Mirosevich J; Clark PE; Giannico GA; Grabowska MM Prostate; 2020 Sep; 80(13):1058-1070. PubMed ID: 32692871 [TBL] [Abstract][Full Text] [Related]
2. Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia. Grabowska MM; Kelly SM; Reese AL; Cates JM; Case TC; Zhang J; DeGraff DJ; Strand DW; Miller NL; Clark PE; Hayward SW; Gronostajski RM; Anderson PD; Matusik RJ Endocrinology; 2016 Mar; 157(3):1094-109. PubMed ID: 26677878 [TBL] [Abstract][Full Text] [Related]
3. m6A Modification Promotes EMT and Metastasis of Castration-Resistant Prostate Cancer by Upregulating NFIB. Shu F; Liu H; Chen X; Liu Y; Zhou J; Tang L; Cao W; Yang S; Long Y; Li R; Wang H; Wang H; Jiang G Cancer Res; 2024 Jun; 84(12):1947-1962. PubMed ID: 38536119 [TBL] [Abstract][Full Text] [Related]
4. Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling. Wang T; Song W; Chen Y; Chen R; Liu Z; Wu L; Li M; Yang J; Wang L; Liu J; Ye Z; Wang C; Chen K Clin Cancer Res; 2016 Mar; 22(6):1531-44. PubMed ID: 26527749 [TBL] [Abstract][Full Text] [Related]
5. Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance. Li S; Hu MG; Sun Y; Yoshioka N; Ibaragi S; Sheng J; Sun G; Kishimoto K; Hu GF Mol Cancer Res; 2013 Oct; 11(10):1203-14. PubMed ID: 23851444 [TBL] [Abstract][Full Text] [Related]
6. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer. Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197 [TBL] [Abstract][Full Text] [Related]
7. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model. Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277 [TBL] [Abstract][Full Text] [Related]
8. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer. Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511 [TBL] [Abstract][Full Text] [Related]
9. Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer. Welti J; Rodrigues DN; Sharp A; Sun S; Lorente D; Riisnaes R; Figueiredo I; Zafeiriou Z; Rescigno P; de Bono JS; Plymate SR Eur Urol; 2016 Oct; 70(4):599-608. PubMed ID: 27117751 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer. Sharp A; Coleman I; Yuan W; Sprenger C; Dolling D; Rodrigues DN; Russo JW; Figueiredo I; Bertan C; Seed G; Riisnaes R; Uo T; Neeb A; Welti J; Morrissey C; Carreira S; Luo J; Nelson PS; Balk SP; True LD; de Bono JS; Plymate SR J Clin Invest; 2019 Jan; 129(1):192-208. PubMed ID: 30334814 [TBL] [Abstract][Full Text] [Related]
11. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response. Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikström P Eur Urol; 2017 May; 71(5):776-787. PubMed ID: 27497761 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor transcriptional activity is required for heregulin-1β-mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase. Jathal MK; Siddiqui S; Vasilatis DM; Durbin Johnson BP; Drake C; Mooso BA; D'Abronzo LS; Batra N; Mudryj M; Ghosh PM J Biol Chem; 2023 Aug; 299(8):104973. PubMed ID: 37380074 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of androgen receptor variants in hormone-sensitive prostate cancer xenografts, castration-resistant sublines, and patient specimens according to the treatment sequence. Honda M; Kimura T; Kamata Y; Tashiro K; Kimura S; Koike Y; Sato S; Yorozu T; Furusato B; Takahashi H; Kiyota H; Egawa S Prostate; 2019 Jun; 79(9):1043-1052. PubMed ID: 30998834 [TBL] [Abstract][Full Text] [Related]
14. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling. Correa RG; Krajewska M; Ware CF; Gerlic M; Reed JC Oncotarget; 2014 Mar; 5(6):1666-82. PubMed ID: 24681825 [TBL] [Abstract][Full Text] [Related]
15. Determining the prognostic significance of IKKα in prostate cancer. Montes M; MacKenzie L; McAllister MJ; Roseweir A; McCall P; Hatziieremia S; Underwood MA; Boyd M; Paul A; Plevin R; MacKay SP; Edwards J Prostate; 2020 Oct; 80(14):1188-1202. PubMed ID: 33258506 [TBL] [Abstract][Full Text] [Related]
16. A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer. Gu P; Chen X; Xie R; Xie W; Huang L; Dong W; Han J; Liu X; Shen J; Huang J; Lin T Mol Cancer; 2019 Jun; 18(1):109. PubMed ID: 31221168 [TBL] [Abstract][Full Text] [Related]
17. Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells. Karacosta LG; Kuroski LA; Hofmann WA; Azabdaftari G; Mastri M; Gocher AM; Dai S; Hoste AJ; Edelman AM Prostate; 2016 Feb; 76(3):294-306. PubMed ID: 26552607 [TBL] [Abstract][Full Text] [Related]
19. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription. Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975 [TBL] [Abstract][Full Text] [Related]
20. Up-Regulation of Follistatin-Like 1 By the Androgen Receptor and Melanoma Antigen-A11 in Prostate Cancer. Su S; Parris AB; Grossman G; Mohler JL; Wang Z; Wilson EM Prostate; 2017 Apr; 77(5):505-516. PubMed ID: 27976415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]